Cemadotin

DCLK1-IN-1 is a selective, in vivo-compatible chemical probe of the doublecortin like kinase 1 (DCLK1) domain that binds to DCLK1 and DCLK2 with IC50 of 9.5 nM and 31 nM, respectively. DCLK1-IN-1 inhibits DCLK1 and DCLK2 kinases with IC50 of 57.2 nM

DCLK1-IN-1 is a selective, in vivo-compatible chemical probe of the doublecortin like kinase 1 (DCLK1) domain that binds to DCLK1 and DCLK2 with IC50 of 9.5 nM and 31 nM, respectively. DCLK1-IN-1 inhibits DCLK1 and DCLK2 kinases with IC50 of 57.2 nM

DP-C-4 is a Cereblon -based dual PROTAC for simultaneous degradation of EGFR and PARP.Appearance:SolidIC50&amp: Target:CereblonIn Vitro:DP-C-4 (1-50 μM: 24 hours) has degradation effects on EGFR and PARP simultaneously in a dose-dependent manner in

Application:WB: 1/1000 – 1/10,000. Predicted molecular weight: 97.5 KDa.

Application:WB: 1/1000 – 1/10,000. Predicted molecular weight: 97.5 KDa.

Application:WB: 1/1000 – 1/10,000. Predicted molecular weight: 97.5 KDa.

Application:WB: 1/1000 – 1/10,000. Predicted molecular weight: 97.5 KDa.

MF: C23H18O4 MF: 358.37 CAS: 909-84-2

CX3CL1 (chemokine (C-X3-C motif) ligand 1) or fractalkine is a membrane protein, which is the only member of CXC3 family. Its chemokine domain (CKD) anchors it to the cell membrane through its mucin-like stalk.

A potent inhibitor of CENP-E (Ki = 3.2 nM) causes mitotic cell cycle delay, leading to apoptosis in various cancer cell lines induces apoptosis in cancer cells in mice bearing xenografts of COLO 205 cells.

A potent inhibitor of CENP-E (Ki = 3.2 nM) causes mitotic cell cycle delay, leading to apoptosis in various cancer cell lines induces apoptosis in cancer cells in mice bearing xenografts of COLO 205 cells.

A potent inhibitor of CENP-E (Ki = 3.2 nM) causes mitotic cell cycle delay, leading to apoptosis in various cancer cell lines induces apoptosis in cancer cells in mice bearing xenografts of COLO 205 cells.